Elsevier Psychotic Disorders: Comorbidity Detection Promotes Improved Diagnosis And Treatment

Product Description Offering an up-to-date perspective on the complexity of mental illness, Psychotic Disorders: Using Co-Morbidity Diagnoses to Enhance Treatment provides unique insight by presenting schizophrenia and psychosis as a cormorbid disorders. Comprehensive coverage of the five comorbidity subtypes includes everything from definitions of the comorbidity syndrome (with DSM-5 criteria) and how to interview to specific symptoms for the psychotic diagnosis, diagnosis, and treatment. This first-of-its-kind reference is a valuable clinical resource for psychiatrists, neurologists, neuropsychiatrists, psychologists, and clinicians in training, as well as a useful tool for exam review. Reflects current research, diagnosis, and treatment options for:  Schizophrenia with Voices and Panic Anxiety  Obsessive-Compulsive Schizophrenia and Obsessive-Compulsive Disorder  Persecutory Delusional Disorder and Social Anxiety   Delusional Depression and Melancholic Depression  Bipolar I Disorder and Atypical Depression  Substance Use Psychoses  Medical Illness and Iatrogenic Psychoses  Covers treatment options and outcomes with medication and psychotherapy.?   Includes sample patient interview approaches and/or biological tests for each diagnosis.  Highlights symptoms, quasi-psychotic symptoms and secondary signs of the comorbidities when alone, and when in conjunction with psychosis.   Reviews diagnosis-specific significance and contributory roles of neurotransmitters, hypofrontality, psychological trauma, and genetics.   Enhanced eBook version allows access to entire book contents on most devices.? Included free with book purchase, or purchase separately.   Review "The editors have organized the text around a remarkable concept that five psychoses account for much of functional psychotic disorders. These five psychotic disorders have common causal factors that contribute to psychosis proneness. Three of these psychoses are already well recognized, and all five appear to be associated with a specific anxiety or depressive disorder. All this implies that neuroleptic treatment, when combined with properly specific anxiety and depression treatment, can make patients much better than with neuroleptics alone. Both editors have contributed to the supporting literature, but there is also a fascinating agenda for further research to explore and expand these concepts. When further documented by additional research, these diagnoses and treatments could have effects on psychotic disorder diagnosis and treatment that could be exceptional, if not ground-breaking. This is clearly a book that needs careful attention in a review, and a wide mental health audience." -- Ira D. Glick, M.D., Professor Emeritus of Psychiatry & Behavioral Sciences, Department of Psychiatry, Stanford University School of Medicine " Anxiety disorders have suffered relative neglect by psychiatry and psychopharmacology over the past several decades. Drs. Veras and Kahn have done the field a great service by putting together a volume that highlights the important overlap of these disorders, not just with mood disorders, but with schizophrenia spectrum illness as well. Psychotic Disorders will serve as a useful reminder of these under-appreciated comorbidities, in the service of more meaningful classification of psychoses and more effective treatment of those suffering from them." -- Edward Silberman, Professor of Psychiatry, Tufts University School of Medicine Review Unique insight into schizophrenia and psychosis from a comorbidity perspective About the Author André Barciela Veras, M.D., PhD, is Professor of Psychiatry in the Medical School of the State University of Mato Grosso do Sul. Fruitful research partnerships and meticulous discussions of clinical experience with superb mentors have contributed immensely to the content of this book. His psychosis research papers all reflect all those collaborations. He graduate